A motivational interviewing (MI) treatment plan documents a client’s current relationship to a specific change, their own reasons for and against it, and how the four processes of MI — engaging, focusing, evoking, and planning — are being used to support movement toward self-directed change. Unlike a generic treatment plan, it isn’t organized around a diagnosis-specific symptom target: MI is a counseling approach rather than a treatment for a specific disorder, so the plan has to specify what MI is being used to accomplish and whether it’s the primary intervention, an adjunct, or a precursor to another treatment.
This guide walks through how to translate MI principles into a defensible, clinically useful treatment plan: how the four processes and OARS organize the clinical work, how to document change talk without turning it into an ad hoc outcome measure, which populations the evidence best supports, a worked example, and common documentation mistakes. This guide is written for licensed mental health professionals and clinicians-in-training working under appropriate supervision; it is educational and does not replace clinical judgment, applicable law, payer requirements, or your profession’s practice standards.
Key Takeaways
- A motivational interviewing treatment plan should document the client’s ambivalence about a specific change, the four processes (engaging, focusing, evoking, planning) guiding the work, and observable change talk — not a generic symptom-reduction goal imported from another modality.
- MI is a counseling style, not a treatment for a specific diagnosis; the treatment plan should specify what MI is being used to accomplish and whether it’s the primary intervention or a precursor to another evidence-based treatment.
- Change talk (language favoring change) and sustain talk (language favoring the status quo) are MI’s own within-session indicators of progress, distinct from a diagnosis-specific symptom measure.
- A 2023 Cochrane review of 93 randomized trials found a small-to-moderate effect of MI on substance use reduction, with more limited and inconsistent evidence for other outcomes — evidence quality varies meaningfully by target behavior and shouldn’t be treated as uniform.
- Comprehensive motivational interviewing treatment plans include 12 core sections spanning diagnosis, formulation, goals, interventions, risk, family involvement, and discharge planning.
- Add Product to WishlistSale!
- Add Product to WishlistSale!
- Add Product to WishlistSale!
View our Counseling Treatment Plan Template, which corresponds with this guide.
Motivational Interviewing Treatment Planning at a Glance
The table below summarizes how core treatment-planning elements typically look in MI, before the guide walks through each in detail.
| Element | Motivational Interviewing Approach |
|---|---|
| What MI targets | A client’s ambivalence about a specific behavior or decision, rather than a diagnosis targeted directly |
| Core structure | Four processes — engaging, focusing, evoking, and planning — that organize the clinical conversation; they often overlap rather than proceeding in strict sequence |
| Core skills | OARS: open-ended questions, affirmations, reflective listening, and summarizing |
| Progress indicator | The pattern of change talk (language favoring change) relative to sustain talk (language favoring the status quo), documented as a clinical process indicator rather than a formal calculated measure |
| Role relative to other treatment | MI may be delivered as a brief standalone intervention or as a precursor/adjunct to another evidence-based treatment; the plan should specify which role applies |
| Evidence base | Most extensively studied for substance use, with evidence for other health and behavioral targets varying by population, outcome, and intervention design |
| Typical course | Often brief (single session to a handful of sessions), though duration varies by setting and purpose |
How to Write a Motivational Interviewing Treatment Plan
At a high level, building an MI treatment plan follows a consistent sequence:
- Identify the specific behavior or decision the client is ambivalent about, and assess current risk and relevant diagnostic criteria.
- Clarify whether MI is the primary intervention or a precursor/adjunct to another evidence-based treatment.
- Engage the client and establish a working relationship before pursuing any specific change agenda.
- Focus the conversation on a specific target behavior or direction, collaboratively where possible.
- Evoke the client’s own reasons for change using OARS skills, tracking change talk versus sustain talk.
- Document a formulation connecting the client’s ambivalence, its sources, and the change talk observed.
- Establish measurable goals and objectives tied to observable change talk and behavioral indicators, not a generic symptom target.
- Move to planning once sufficient change talk and commitment language are present, not on a fixed schedule.
- Reassess risk and diagnosis on an ongoing basis, independent of the client’s engagement level.
- Revise the plan collaboratively as the client’s ambivalence shifts.
Why Treatment Planning Matters for Motivational Interviewing
MI is a client-centered counseling style that aims to strengthen a person’s own motivation and commitment to change by exploring and resolving ambivalence, in an atmosphere of acceptance and compassion (Miller & Rollnick, 2023). Because MI targets ambivalence rather than a diagnosis directly, a treatment plan built around it has to specify something most other treatment plans don’t: what MI is actually being used to accomplish, and whether it’s the primary intervention or a precursor to another treatment the client isn’t yet ready to engage with.
A comprehensive treatment plan still serves the same administrative purposes it does in any modality: it documents medical necessity, supports continuity of care, and creates measurable benchmarks. MI is often delivered briefly — sometimes in a single session — though this varies considerably by setting and purpose, and the plan should reflect a realistic, individualized course rather than assuming a fixed length by default.
Complete a Thorough Clinical Assessment Before Writing the Treatment Plan
A treatment plan should never be developed in isolation. Before identifying goals, clinicians should complete an assessment covering the presenting concern, current risk, relevant diagnostic criteria, and — central to MI specifically — the client’s own account of their ambivalence: what draws them toward the change, what holds them back, and any change talk or sustain talk already present in how they describe it.
MI’s assessment approach is itself collaborative rather than clinician-driven in the way a structured diagnostic interview is; much of what would be “assessment data” in another modality emerges through the engaging and focusing processes rather than a separate intake step. This doesn’t reduce the need for a thorough risk assessment and diagnostic clarity — both remain necessary regardless of therapeutic approach.
If you are looking for additional guidance on collecting assessment information before creating a treatment plan, our guides to the Counseling Intake Assessment and Biopsychosocial Assessment provide more detailed recommendations for conducting comprehensive evaluations.
How a Motivational Interviewing Treatment Plan Differs From a Generic One
The table below highlights the key differences at a glance, each explained in more detail throughout this guide.
| Generic Treatment Plan | Motivational Interviewing Treatment Plan |
|---|---|
| Diagnosis-centered formulation | Ambivalence-centered formulation tied to a specific change |
| Symptom-reduction goals | Goals tied to observable change talk and movement toward commitment |
| Clinician-defined treatment targets | Collaboratively focused target, evoked from the client’s own reasons |
| Standalone treatment episode | Often a precursor or adjunct to another evidence-based treatment |
| Standardized symptom measures | Change talk/sustain talk tracking, alongside standardized measures where appropriate |
| Fixed session-count assumption | Often brief, but individualized to the client’s own pace of movement toward change |
What to Include in a Motivational Interviewing Treatment Plan
A comprehensive MI treatment plan connects the client’s ambivalence, the four processes guiding the work, and observable change talk into a clinical roadmap. It follows the same 12-section framework used across TherapyByPro’s treatment-plan guides.
Important: There is no single universally required “motivational interviewing treatment plan” format. MI does not prescribe a standardized 12-section treatment-plan structure. The framework below is a practical clinical documentation structure adapted for MI — not a component of the model itself — and it can be adapted to organizational, payer, licensing, and jurisdictional requirements.
| Treatment Plan Section | Purpose |
|---|---|
| Client and Plan Information | Documents client demographics, treatment plan dates, review dates, plan type, clinician information, practice details, session format, frequency, and estimated treatment duration. |
| Coordinating Providers and Services | Identifies other providers, agencies, referrals, releases of information, and care coordination plans to support continuity of treatment. |
| Diagnostic Summary | Documents the client’s diagnosis, where applicable, and the clinical evidence supporting it, kept separate from the ambivalence-based formulation below. |
| Clinical Formulation and Treatment Rationale | Explains the client’s ambivalence about the specific change, its sources, existing motivation, values, and change talk already present, realistic barriers such as strong sustain talk or ambivalence about even discussing the target behavior, and the clinical reasoning connecting them to the selected role for MI (primary intervention or precursor/adjunct). |
| Medication and Concurrent Treatment | Documents current medications, prescribing providers, medication response, adherence concerns, and other behavioral health or medical services involved in care. |
| Presenting Problems and Functional Impact | Describes the client’s symptoms and how the target behavior affects functioning, distinct from the ambivalence formulation itself. |
| Treatment Goals and Objectives | Establishes goals tied to observable change talk and movement toward commitment, each with its own baseline ambivalence and change talk/sustain talk pattern, planned processes and OARS skills, clinical rationale, and progress tracking, with measurable short-term objectives connected to each. |
| Treatment Modality and Interventions | Documents the primary treatment modality, overall clinical rationale, session format and frequency, and any between-session tasks, which are often minimal or absent in brief MI. |
| Risk Assessment and Safety Planning Summary | Summarizes current and historical risk factors, assessed explicitly and individually rather than assumed from the target behavior or the client’s engagement level. |
| Family, Support, and Collateral Involvement | Documents family and support involvement, including whether significant others reinforce ambivalence or support the client’s own reasons for change. |
| Transition and Discharge Planning | Defines discharge or transition criteria tied to the client’s own movement toward commitment and any decisions they’ve made, and referrals for continued or follow-on treatment. |
| Plan Review and Signatures | Documents treatment plan updates, overall progress, client participation, and signatures. |
If you want to document these elements in a structured format, the TherapyByPro Counseling Treatment Plan template follows this same clinical workflow.
The following sections provide a detailed overview of each component.
1. Client and Plan Information
Document the estimated treatment duration realistically — MI is often brief, and the plan shouldn’t default to a longer generic timeframe unless MI is being delivered as an ongoing component of broader treatment.
2. Coordinating Providers and Services
Document any other providers involved and the plan for coordination, particularly relevant when MI is being used as a precursor to a referral (e.g., substance use treatment) the client isn’t yet engaged with.
3. Diagnostic Summary
Name the definitive diagnosis where one is established and the clinical evidence supporting it. MI does not have its own ICD-10-CM diagnosis code; diagnosis and coding should reflect the client’s clinical presentation and applicable coding and documentation requirements rather than the counseling approach used, and not every MI encounter necessarily requires a psychiatric diagnosis — this depends on the clinical context, service, setting, and payer.
4. Clinical Formulation and Treatment Rationale
Document the client’s ambivalence about the specific target behavior — what draws them toward change, what holds them back — and the clinical reasoning for why MI, and which of its four processes, fits this point in the client’s readiness.
Clinical Documentation Note: A formulation that names the target behavior without describing the actual content of the client’s ambivalence (their own stated reasons for and against change) usually isn’t specific enough to guide session-to-session work — MI’s formulation lives in the client’s own words, not a clinician-inferred motivation.
Document existing change talk, values, and motivation already present, alongside realistic barriers such as strong, consistent sustain talk or ambivalence about the conversation itself.
5. Medication and Concurrent Treatment
Document medications, prescribing providers, and response; note whether medication and MI are addressing the same target behavior or different concerns.
6. Presenting Problems and Functional Impact
Document the presenting concern and its functional impact with specificity, kept distinct from the ambivalence-based formulation — this section establishes medical necessity, not the client’s motivational state.
7. Treatment Goals and Objectives
Goals should be tied to observable change talk and movement toward commitment language, not a diagnosis-derived symptom-reduction target imported from another modality. Each goal should include its own baseline ambivalence and the pattern of change talk and sustain talk observed regarding the target behavior, alongside current functioning and a standardized measure when clinically or administratively appropriate — this is the reference point subsequent sessions will be tracked against. Each goal should also specify which of the four processes (engaging, focusing, evoking, planning) and which OARS skills are being used to pursue it, and connect each to the client’s current point in resolving their ambivalence, along with a method for tracking progress.
8. Treatment Modality and Interventions
Document the primary treatment modality as a whole, session format, and frequency — distinct from the goal-specific interventions documented in section 7. Between-session assignments are often minimal or absent in brief MI; where MI is delivered alongside another treatment, this section should distinguish MI sessions from that treatment’s own between-session structure.
9. Risk Assessment and Safety Planning Summary
Document current and historical risk factors with the same specificity expected in any treatment plan. A client’s engagement or apparent motivation in session doesn’t reduce the need for explicit, individualized risk assessment. MI can support engagement and explore ambivalence, but it isn’t a substitute for indicated assessment, stabilization, or evidence-based treatment when a client has acute safety concerns, significant withdrawal risk, severe impairment, or another condition requiring more immediate or specialized intervention — in those situations, MI may still have a role, but it shouldn’t be the only thing documented in the plan.
10. Family, Support, and Collateral Involvement
Document family and support involvement, including whether significant relationships tend to reinforce the client’s ambivalence or support the reasons for change the client has voiced themselves.
11. Transition and Discharge Planning
Discharge or transition criteria should be tied to the client’s own movement toward commitment and the decisions they’ve made — and where MI was used as a precursor, to successful engagement with the treatment it was meant to lead into — rather than a fixed session count or an expectation that ambivalence must be fully resolved first.
12. Plan Review and Signatures
Document review dates, client participation, and signatures, reinforcing that treatment planning remains collaborative, consistent with MI’s own spirit of partnership.
Motivational Interviewing Treatment Plan Example
The following example demonstrates how the clinical sections of an MI treatment plan connect together for a client presenting with ambivalence about reducing alcohol use. This example is provided for educational purposes only and should be adapted based on the individual client’s presentation, diagnosis, and applicable documentation requirements.
| Section | Example Documentation | Clinical Purpose |
|---|---|---|
| Client & Plan Information | Plan Type: Initial Treatment Plan Service Format: Individual outpatient MI Frequency: Weekly sessions, reassessed after initial engagement Estimated Duration: Brief course (2–4 sessions), to be extended or transitioned based on progress Primary Concern: Ambivalence about alcohol use following a medical referral, not yet client-initiated | Establishes realistic scope for brief MI, distinct from ongoing treatment for a diagnosed condition. |
| Coordinating Providers and Services | Other Providers: Referring primary care provider; no current substance use treatment provider. Release of Information: ROI obtained for coordination with primary care provider. Care Coordination Plan: If the client’s own commitment language points toward reducing use, discuss referral to a structured substance-use-focused treatment. | Documents MI’s role as a possible precursor to further treatment, not assumed to be the endpoint. |
| Diagnostic Summary | Diagnosis: Diagnostic status under evaluation; assessment to date does not yet establish criteria for a substance use disorder based on available information. Diagnostic Considerations: Differential diagnosis and diagnostic status should be reviewed as clinically indicated as further information becomes available. | Avoids asserting a diagnosis the current assessment doesn’t yet support. |
| Clinical Formulation & Treatment Rationale | Client presents with genuine ambivalence about alcohol use: reasons to continue (stress relief, social habit) alongside emerging reasons for concern (spousal comments, fatigue), the latter voiced spontaneously rather than prompted — an early instance of change talk. Client did not self-refer, which is itself relevant context for engagement. Strengths: Stable marriage, employment, and spontaneous mention of spousal concern (early change talk). Barriers: Client did not self-refer and initially minimizes the concern; strong, consistent sustain talk around stress relief and social habit. Treatment Rationale: MI was selected specifically because the client isn’t yet committed to change; the goal at this stage is exploring ambivalence, not assuming a treatment target the client hasn’t endorsed, consistent with MI’s evidence base for substance-use-related ambivalence (Miller & Rollnick, 2023; Schwenker, Dietrich, Hirpa, Nothacker, Smedslund, Frese, & Unverzagt, 2023). | Explains the clinical reasoning connecting the client’s actual ambivalence, strengths, and barriers to the selected approach, without overstating readiness. |
| Medication and Concurrent Treatment | Current Medication: None; client is not currently taking psychiatric medication. Consideration: Medication evaluation is not part of the current treatment plan; referral or consultation can be considered if the diagnostic picture becomes clearer or symptoms warrant it. | Documents current medication status without asserting a conclusion the available information doesn’t support. |
| Presenting Problems & Functional Impact | Presenting Problem: Elevated alcohol use flagged at a routine medical visit; not self-identified by the client as a problem at intake. Functional Impact: Client reports increased fatigue; spouse has raised the topic twice recently, suggesting some relational strain. | Establishes medical necessity concisely, distinct from the ambivalence formulation itself. |
| Treatment Goals and Objectives | Baseline Severity and Current Functioning: Client describes drinking most evenings; change talk present but outweighed by sustain talk at this stage. Employed full-time; stable marriage currently showing some strain related to the target behavior. Presenting Concern: Elevated alcohol use flagged externally; client currently ambivalent, with sustain talk (stress relief, social habit) more prominent than change talk at this stage. Clinical Outcome Goal: Client will clarify their own relationship to alcohol use and make a self-directed decision about whether and how to change it — the specific decision belongs to the client, not a predetermined target. MI Process Objective 1: Client will articulate at least two self-generated reasons for considering a change in alcohol use by the third session, documented in the client’s own words in session notes. MI Process Objective 2: Clinician will document the frequency and strength of change talk and sustain talk each session, noting the pattern over time rather than a formally calculated ratio. Behavioral Objective (contingent on readiness): If and when the client articulates commitment language regarding a specific change, client will identify one concrete next step connected to their own stated goals (e.g., health, sleep, the relationship strain they’ve named), to be reviewed collaboratively. Goal-Specific Intervention: Engaging and focusing processes in early sessions, shifting toward evoking as change talk emerges; OARS skills used throughout, particularly reflective listening of ambivalence. Clinical Rationale for This Goal: The client’s spontaneous mention of spousal concern and fatigue offers entry points for evoking further exploration of the client’s own reasons; moving to a specific change plan before the client has voiced much change talk risks working against their own process, though ambivalence doesn’t need to fully resolve before some planning becomes appropriate. Goal Progress: Session-by-session clinician documentation of change talk and sustain talk observed; client’s own stated reasons documented each session; reassess at session 4, considering referral to structured substance use treatment if the client’s own commitment language and stated goals point that direction, or continuing engaging/focusing work if ambivalence remains prominent. | Demonstrates the reasoning chain from baseline through the client’s own emerging concerns to a client-defined direction and a measurable review point, without substituting change talk itself for the clinical outcome. |
| Treatment Modality and Interventions | Primary Modality: Individual outpatient MI, weekly sessions. Between-Session Assignments: None formally assigned at this stage, consistent with brief MI’s typically minimal between-session structure. | Documents the overall treatment approach and the appropriately limited between-session structure for early-stage MI — distinct from the goal-specific intervention above. |
| Risk Assessment & Safety Planning Summary | Assessment Finding: Client denies current suicidal ideation, intent, plan, or access to means; denies any history of self-harm. Clinical Interpretation: Current risk is assessed as low based on the documented assessment, including current ideation, intent, plan, history, relevant risk factors, protective factors, and overall clinical presentation. This determination reflects the clinician’s overall assessment rather than being inferred solely from denial of suicidal ideation, the client’s engagement level, or the nature of the presenting concern. Protective Factors: Stable marriage, employment, no prior mental health history. Plan: No additional safety-planning intervention is indicated based on the current assessment; risk will be reassessed as clinically indicated. | Documents an explicit, individualized risk assessment rather than an inference from the client’s presentation or motivational stage. |
| Family, Support, and Collateral Involvement | Support System: Client’s spouse has raised the topic directly, suggesting a potential ally in supporting change, though not currently involved in sessions. Collateral Involvement: Not currently indicated; client is an adult managing their own care. Involving the spouse directly may be considered later with client consent if it appears likely to support, rather than pressure, the client’s own process. | Documents relevant supports appropriate to an adult client’s autonomy, consistent with MI’s collaborative stance. |
| Transition and Discharge Planning | Discharge/Transition Criteria: Sustained increase in change talk and commitment language, with successful engagement in a referral to structured substance use treatment if indicated, or a documented, informed decision by the client not to pursue further treatment at this time. Aftercare Plan: Client may return for further MI sessions if ambivalence resurfaces or circumstances change. | Establishes discharge criteria tied to the client’s own movement and decisions, not a fixed session count or a requirement that ambivalence be fully resolved. |
| Plan Review and Signatures | Progress Status: Formal treatment-plan review scheduled at session 4 or sooner if clinically indicated. Client Participation: Treatment goals were constructed collaboratively, reflecting the client’s own stated ambivalence rather than a clinician-imposed target. Client signature obtained to confirm participation in treatment planning. | Reinforces that the treatment plan was built with the client, not imposed on them. |
Motivational Interviewing Treatment Plan Template
The images below provide a preview of TherapyByPro’s Counseling Treatment Plan template, designed for mental health professionals who need a structured framework for documenting MI treatment goals, measurable objectives, clinical formulation, interventions, risk considerations, and treatment progress.
The template follows a comprehensive clinical structure that can be adapted for MI delivered as a standalone brief intervention or as a precursor to another treatment. It includes sections for client and plan information, care coordination, diagnostic summary, clinical formulation, medication and concurrent treatment, presenting problems and functional impairment, treatment goals, objectives, interventions, treatment modality, risk assessment, family and support involvement, discharge planning, and plan review documentation.
Organized across 15 dedicated pages, the editable Word document and fillable PDF allow clinicians to customize documentation based on their practice setting, clinical approach, and documentation requirements while maintaining a consistent treatment planning workflow.
Clinicians seeking a complete treatment planning solution can access TherapyByPro’s Counseling Treatment Plan template. For clinicians who need a streamlined tool focused specifically on documenting treatment goals, objectives, and interventions, the Treatment Plan Goals template provides a simplified format for tracking progress across multiple treatment goals.
The Four Processes and OARS: How MI Organizes the Clinical Work
This is the single most important structural difference between an MI treatment plan and a diagnosis-driven one — though it’s worth being precise about what the four processes actually are. They aren’t a case formulation model in the sense that a CBT core-belief model or a schema formulation is; they describe the flow and tasks of the MI conversation itself. The formulation still needs its own content: the client’s presenting concern, their ambivalence, their own reasons for and against change, relevant contextual factors, and the clinical rationale for using MI at all. The four processes organize how the clinician approaches that content session to session (Miller & Rollnick, 2023):
- Engaging — establishing a working relationship before pursuing any change agenda. Engagement supports the later processes, though the four processes often overlap and revisit one another rather than proceeding in strict sequence.
- Focusing — clarifying the specific direction or target behavior the conversation will center on, ideally negotiated collaboratively rather than assumed by the clinician.
- Evoking — drawing out the client’s own reasons for change, using OARS skills to notice and reinforce change talk as it emerges.
- Planning — developing a concrete change plan when the client’s readiness and commitment support it. Planning should be responsive to the client’s own pace rather than imposed on a fixed schedule; moving to a specific plan before a client has generated much change talk can be counterproductive, though ambivalence doesn’t necessarily need to be fully resolved before meaningful planning or action can begin.
OARS — open-ended questions, affirmations, reflective listening, and summarizing — are the core communication skills used throughout all four processes, particularly during evoking. A reflective listening statement that accurately captures a client’s ambivalence, for instance, often does more to evoke further change talk than a direct question would.
Change talk and sustain talk are clinically meaningful MI process indicators, not a standardized outcome measure. Change talk — client language favoring change, often categorized using the DARN-CAT framework (desire, ability, reason, need, followed by commitment, activation, and taking steps) — and sustain talk — language favoring the status quo — are worth documenting, but how they’re coded and how much weight they carry depends on the clinician’s training, the documentation system in use, and the purpose of the assessment. A treatment plan shouldn’t imply a formally calculated “ratio” is a routine clinical measure; documenting the frequency, strength, or pattern of change talk and sustain talk across sessions is more defensible. Standardized symptom or functional measures remain appropriate where the presenting problem calls for them — MI process indicators supplement, rather than replace, clinically appropriate outcome measurement.
Documenting MI Fidelity, Not Just MI’s Presence
Writing “MI” as the intervention doesn’t establish that MI was actually delivered with fidelity. Generic supportive counseling and genuinely MI-consistent practice can look similar on paper but aren’t the same thing. Fidelity involves the underlying spirit of partnership, acceptance, compassion, and evocation; MI-consistent use of OARS; genuine attention to change and sustain talk rather than a directive stance aimed at convincing the client; and appropriate training or supervision behind any claim of MI competence. The Motivational Interviewing Treatment Integrity code (MITI) is the most widely used structured fidelity measure in MI research and training, and clinicians documenting MI-specific work can reference it as a standard for what MI-consistent practice actually looks like, without needing to formally code every session against it (Moyers, Rowell, Manuel, Ernst, & Houck, 2016).
In the treatment plan, the four processes and OARS organize the clinical work; the formulation still needs to document the client’s actual ambivalence and reasons, the goals section is built from movement toward the client’s own commitment language, and the interventions section specifies which process and skills are genuinely in use — not a generic “MI provided” label.
Selecting MI Delivery for Presentation and Population
MI has been extensively studied for substance use and has also been evaluated across a range of other health and behavioral targets, with effects varying considerably by population, outcome, and intervention design. Evidence for MI as a broad approach shouldn’t be read as evidence that it’s equally effective for every target behavior, and evidence for interventions that merely incorporate MI alongside other components shouldn’t be treated as equivalent to evidence for standalone MI.
| Population / Presentation | Treatment-Planning Priorities | Evidence Context |
|---|---|---|
| Substance use, including alcohol and drug use | Exploring ambivalence about use directly; considering MI as a precursor to structured substance use treatment when readiness increases. | The most extensively studied application; a 2023 Cochrane review of 93 randomized trials (22,776 participants) found a small-to-moderate effect on substance use reduction and a smaller effect on treatment retention, though the authors noted moderate-to-low confidence in the evidence overall (Schwenker, Dietrich, Hirpa, Nothacker, Smedslund, Frese, & Unverzagt, 2023). |
| Health behavior change (e.g., physical activity, medication adherence) | Integrating MI within a broader behavioral health intervention rather than as a standalone treatment. | A 2024 systematic review and meta-analysis found behavioral interventions incorporating MI produced modest improvements in physical activity outcomes, though effects varied by intervention design and population (Zhu, Sinha, Kirk, Michalopoulou, Hajizadeh, Wren, Doody, Mackillop, Smith, Jebb, & Astbury, 2024). |
| Precursor or adjunct to another evidence-based treatment | Explicitly documenting MI’s role as building readiness for a specific subsequent treatment, with clear criteria for when that transition should occur. | A common and well-supported clinical application, though the treatment plan should name the specific downstream treatment MI is building toward rather than leaving that connection implicit. |
| General treatment engagement and ambivalence about starting care | Using MI’s engaging and evoking processes before assuming a client is ready for a specific treatment modality. | A broad, commonly cited rationale for MI use; a comprehensive 2018 review of reviews found most of the underlying meta-analytic evidence for MI across health and social care settings to be low or very low quality, with moderate-quality evidence limited to a small subset of specific outcomes (Frost, Campbell, Maxwell, O’Carroll, Dombrowski, Williams, Cheyne, Coles, & Pollock, 2018). |
Clinical takeaway: MI’s evidence base is genuinely strongest for substance use and weaker and more mixed elsewhere — the treatment plan should reflect that honestly rather than treating “MI works” as a uniform claim across every target behavior.
Establish Clinical Necessity Through Functional Impairment
Documentation should establish the clinical rationale for services — relevant symptoms, functional impact, health or behavioral consequences, risk, diagnosis where applicable, and treatment rationale — in the form appropriate to the specific setting and payer, rather than assuming one documentation convention applies universally. Describe the observable consequence tied to the target behavior: relational strain, occupational impact, or health effects. Connecting functional impairment to the ambivalence formulation, rather than listing symptoms and motivational stage as separate items, demonstrates the clinical reasoning that makes the plan genuinely individualized.
Creating Measurable Motivational Interviewing Goals
Effective treatment goals should be individualized, collaborative, and measurable — and in MI specifically, they should be tied to observable change talk and movement toward commitment rather than a clinician-imposed behavioral target the client hasn’t voiced themselves.
| Weak Goal | Stronger Goal |
|---|---|
| Reduce alcohol use. | Increase the client’s self-generated change talk regarding alcohol use, documented across sessions, with a formal reassessment of readiness at a defined review point. |
| Get the client to quit smoking. | Client will articulate at least two personally meaningful reasons for considering a change in smoking, tracked verbatim in session notes. |
| Improve medication adherence. | Client will identify and voice their own ambivalence about medication adherence, with change talk tracked relative to sustain talk across sessions. |
| Motivate the client to enter treatment. | Client will demonstrate commitment language (e.g., stating an intention or specific next step) regarding engagement with a specific treatment referral, documented in session. |
Motivational Interviewing Goal Examples
MI treatment goals work best when they distinguish three related but different things: the clinical outcome goal (the change the client ultimately wants in their life or behavior), MI process objectives (what the clinician documents as the client moves toward that change — articulated reasons, increased confidence, commitment language), and behavioral objectives (concrete actions, appropriate once the client is ready to plan). Change talk itself is a process indicator, not the clinical outcome — a plan where “more change talk” quietly becomes the treatment goal has lost the client’s actual objective.
Goal 1: Establish Engagement and a Collaborative Focus
Typically the earliest goal, before any specific change agenda is pursued.
Clinical Outcome Goal: Client will engage in an open conversation about the target concern and collaboratively identify a focus for continued work.
Possible MI Process Objectives:
- Client will articulate, in their own words, what brought them to this conversation.
- Client and clinician will collaboratively identify a specific target behavior or direction for focus.
- Client will demonstrate continued engagement (attendance, willingness to discuss the target) across the first two sessions.
Possible Interventions: Engaging process, open-ended questions, reflective listening establishing rapport before any change agenda is introduced.
Goal 2: Explore Ambivalence and the Client’s Own Reasons for Change
The central evoking-stage goal, and often the bulk of the clinical work.
Clinical Outcome Goal: Client will clarify their own values and reasons regarding the target behavior, informing whatever decision they ultimately make.
Possible MI Process Objectives:
- Client will articulate at least one self-generated reason for change per session.
- Clinician will document the frequency, strength, and pattern of change talk and sustain talk observed each session, as appropriate to the clinician’s documentation approach.
- Client will demonstrate DARN-language (desire, ability, reason, or need statements) regarding the target behavior.
Possible Interventions: Evoking process using OARS skills, particularly reflective listening that draws out change talk without arguing against sustain talk.
Goal 3: Develop and Commit to a Change Plan
Introduced when the client’s own readiness supports it, not on a fixed schedule.
Clinical Outcome Goal: Client will make and act on a self-directed decision regarding the target behavior, whatever that decision turns out to be.
Possible MI Process Objectives:
- Client will articulate commitment language (e.g., “I will,” “I’m going to”) regarding a specific next step.
Possible Behavioral Objectives (once the client is ready to plan):
- Client will identify at least one concrete next step toward the change they’ve described.
- Client will follow through on the identified step, reported and reviewed in the following session.
Possible Interventions: Planning process, collaborative goal-setting, summarizing accumulated change talk to support commitment.
Remember that these examples are starting points. The specific ambivalence, change talk, and goals should reflect this client’s own words — a change plan introduced well before the client has voiced much change talk doesn’t reflect MI-adherent treatment planning, though ambivalence doesn’t need to be fully resolved before some planning or action becomes appropriate.
Documentation Language Clinicians Can Use
MI has its own documentation vocabulary. Each example below shows the full chain: what the client said, the MI-relevant interpretation, the intervention or process in use, and what it means for the plan — replace the illustrative client language with the client’s actual words in real documentation.
- Change talk identified: Client mentioned their spouse’s recent comments about their drinking, unprompted. This is change talk (a reason favoring change) not present earlier in the session; clinician reflected it to invite further exploration rather than moving to advice-giving.
- Sustain talk identified: Client described drinking as their main way of managing stress after work. Documented as sustain talk to be explored with curiosity, not challenged directly, consistent with the evoking process.
- Reflective listening in use: Client expressed both worry and reluctance to change. Clinician reflected the ambivalence directly (“part of you is worried, part of you isn’t ready”) without pushing toward either side, supporting continued engagement.
- Process transition: Once the client identified alcohol use as the topic they wanted to focus on, the session shifted from focusing to evoking, and subsequent questions centered on the client’s own reasons regarding that specific behavior.
- Commitment language: Client stated an intention to cut back starting that week. Documented as commitment language; clinician moved toward the planning process and helped the client specify what “cutting back” would concretely look like.
Common Documentation Mistakes When Writing a Motivational Interviewing Treatment Plan
Even experienced clinicians can develop documentation habits that reduce the clinical usefulness of an MI treatment plan — the following examples highlight common mistakes and how to strengthen the documentation.
| Common Documentation Mistake | Why It Is a Problem | Example of Weak Documentation | Example of Stronger Documentation |
|---|---|---|---|
| Writing goals as clinician-imposed behavior targets | A goal the client hasn’t voiced themselves — however clinically reasonable — doesn’t reflect MI’s evoking-based approach to goal formation. | “Goal: client will quit drinking.” | “Clinical outcome goal: client will clarify their own relationship to alcohol use and reach a self-directed decision. MI process objective: client will articulate self-generated reasons regarding the behavior, tracked across sessions.” |
| Moving to a change plan before sufficient change talk is present | A plan introduced well before much change talk has emerged risks working against the client’s own process rather than supporting it — pacing matters, though ambivalence doesn’t need to be fully resolved first. | “Session 1: developed a plan to reduce drinking.” | “Session 1: engaging and focusing; some change talk emerging but not yet substantial. Continued evoking planned for next session.” |
| Treating any supportive conversation as “MI” | General empathy or encouragement isn’t the same as MI’s specific structure and skill set; documentation should reflect the actual processes and OARS skills used. | “Provided supportive counseling.” | “Used reflective listening and open-ended questions during the evoking process, reinforcing client-generated change talk.” |
| Failing to document MI’s role relative to other treatment | Without specifying whether MI is standalone or a precursor to something else, the plan doesn’t clarify what a successful outcome actually looks like. | “Client receiving MI for substance use.” | “MI being used to build readiness for referral to structured substance use treatment; transition criteria specified below.” |
| Assuming risk is inherently low because the client seems motivated or engaged | Client engagement or apparent motivation doesn’t reduce actual clinical risk; it should be assessed explicitly and individually regardless of the client’s presentation. | “No safety concerns; client is engaged and motivated.” | “Suicide risk assessed explicitly at intake; client denies current ideation, intent, or plan, and denies self-harm history.” |
Clinical Documentation Note: The documentation gap that shows up most often in MI treatment plans isn’t the goals section — it’s writing “MI provided” without ever recording the actual change talk or sustain talk the client offered. Those specific words are what make the chart useful for tracking whether the client is actually moving toward change, not just that a supportive conversation happened.
Frequently Asked Clinical Questions
The following questions address common clinical documentation considerations for mental health professionals developing motivational interviewing treatment plans.
What are the four processes of motivational interviewing?
Engaging, focusing, evoking, and planning. They often overlap rather than proceeding strictly in order, but the treatment plan should reflect which process is currently guiding the work, since that determines what’s clinically appropriate to do next — moving to planning before sufficient change talk is present tends to increase resistance rather than commitment.
What is change talk and why does it matter for treatment planning?
Change talk is client language favoring change, often categorized using the DARN-CAT framework (desire, ability, reason, need, then commitment, activation, taking steps). It functions as MI’s own within-session progress indicator — goals and objectives should be tied to observable change talk rather than a generic symptom-reduction target.
Does a motivational interviewing treatment plan need a diagnosis?
Where clinically applicable, yes, but MI doesn’t have its own ICD-10-CM diagnosis code — diagnosis and coding should reflect the client’s clinical presentation and applicable requirements, not the counseling approach used. Not every MI encounter requires a psychiatric diagnosis; this depends on the setting, service, and payer. The diagnostic summary should remain accurate and specific, documented separately from the ambivalence-based formulation that drives most of the plan’s clinical reasoning.
Is MI used on its own or with other treatments?
Both, and the treatment plan should specify which. MI is often used as a precursor or adjunct to build readiness for another evidence-based treatment the client isn’t yet engaged with, but it can also be delivered as a standalone brief intervention, particularly for substance use.
What are examples of motivational interviewing treatment goals?
Goals should distinguish the client’s own clinical outcome (the change they ultimately want in their life or behavior) from MI process objectives that mark movement toward it — such as articulated reasons for change, increased confidence, or commitment language — and, when the client is ready, concrete behavioral objectives. Change talk is a meaningful process indicator, not a clinical outcome in itself; a plan shouldn’t treat “more change talk” as the goal.
How should risk be documented in a motivational interviewing treatment plan?
Risk should be assessed explicitly and individually, the same as in any other modality. A client’s apparent motivation or engagement in session shouldn’t be treated as a reason to document risk more casually — it should be assessed with the same rigor and documented separately from the ambivalence formulation.
Conclusion: Creating Effective Motivational Interviewing Treatment Plans That Support Meaningful Clinical Progress
An effective motivational interviewing treatment plan does more than list goals — it documents the client’s actual ambivalence, the four processes guiding the work, and observable change talk, while specifying MI’s role relative to any other treatment and still meeting the diagnostic and risk-documentation standards any treatment plan requires. When thoughtfully developed, it reflects how MI actually works: evoking the client’s own reasons for change rather than imposing a clinician-selected target.
Clinicians should remember that motivational interviewing treatment plans, like any other, are living documents — and given how directly MI’s pacing depends on the client’s own readiness, the plan should be revised as ambivalence shifts rather than followed on a fixed schedule regardless of where the client actually is. Regular review of change talk, sustain talk, and current risk helps ensure that treatment remains genuinely responsive to what this specific client is ready for.
TherapyByPro is a trusted resource for mental health professionals worldwide. Our therapy tools are designed with one mission in mind: to save you time and help you focus on what truly matters-your clients. Every worksheet, counseling script, and therapy poster in our shop is professionally crafted to simplify your workflow, enhance your sessions, reduce stress, and most of all, help your clients.
Want to reach more clients? We can help! TherapyByPro is also a therapist directory designed to help you reach new clients, highlight your expertise, and make a meaningful impact in the lives of others.
- Add Product to WishlistSale!
- Add Product to WishlistSale!
- Add Product to WishlistSale!
References
- Frost, H., Campbell, P., Maxwell, M., O’Carroll, R. E., Dombrowski, S. U., Williams, B., Cheyne, H., Coles, E., & Pollock, A. (2018). Effectiveness of Motivational Interviewing on adult behaviour change in health and social care settings: A systematic review of reviews. PLoS ONE, 13(10), e0204890. Resource
- Miller, W. R., & Rollnick, S. (2023). Motivational Interviewing: Helping People Change and Grow (4th ed.). Guilford Press. Resource
- Moyers, T. B., Rowell, L. N., Manuel, J. K., Ernst, D., & Houck, J. M. (2016). The Motivational Interviewing Treatment Integrity Code (MITI 4): Rationale, preliminary reliability and validity. Journal of Substance Abuse Treatment, 65, 36–42. Resource
- Schwenker, R., Dietrich, C. E., Hirpa, S., Nothacker, M., Smedslund, G., Frese, T., & Unverzagt, S. (2023). Motivational interviewing for substance use reduction. Cochrane Database of Systematic Reviews, 12(12), CD008063. Resource
- Zhu, S., Sinha, D., Kirk, M., Michalopoulou, M., Hajizadeh, A., Wren, G., Doody, P., Mackillop, L., Smith, R., Jebb, S. A., & Astbury, N. M. (2024). Effectiveness of behavioural interventions with motivational interviewing on physical activity outcomes in adults: Systematic review and meta-analysis. BMJ, 386, e078713. Resource